1h Free Analyst Time
The publisher has been monitoring the lice treatment market and it is poised to grow by $ 128.97 mn during 2022-2026, progressing at a CAGR of 6.26% during the forecast period. This report on the lice treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of lice infestation, rising healthcare expenditure, and easy availability of lice treatment products.
The lice treatment market analysis includes the distribution channel segment and geographic landscape.
The lice treatment market is segmented as below:
By Distribution Channel
- Hospitals and clinics
- Online
- Retail pharmacies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing population of children as one of the prime reasons driving the lice treatment market growth during the next few years. Also, rising investments for R&D in targeted therapies and the emergence of novel treatment options will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
This report on lice treatment market covers the following areas:
- Lice treatment market sizing
- Lice treatment market forecast
- Lice treatment market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lice treatment market vendors that include Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG. Also, the lice treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Distribution Channel
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Executive Summary
The Publisher Announces the Publication of its Research Report - Global Lice Treatment Market 2022-2026The publisher recognizes the following companies as the key players in the global lice treatment market: Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG.
Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is growing population of children.'
According to the report, one of the major drivers for this market is the increasing prevalence of lice infestation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alliance Pharma Plc
- American Vanguard Corp.
- Arbor Pharmaceuticals LLC
- Elanco Animal Health Inc.
- Fleming Medical Ltd.
- Johnson and Johnson Inc.
- Logic Product Group LLC
- Marico Ltd.
- Merck and Co. Inc.
- Nix Pharma Pvt Ltd.
- PARAPRO LLC
- Perrigo Co. Plc
- Prestige Consumer Healthcare Inc.
- SHIONOGI Co. Ltd.
- TecLabs Inc.
- Teva Pharmaceutical Industries Ltd.
- Thornton & Ross Ltd.
- Bayer AG
